Amaral José Araujo, De Franco Milene Tino, Zapata-Quintanilla Lucy, Carbonare Solange Barros
Laboratório de Imunogenética, Instituto Butantan, Av. Dr. Vital Brasil, 1500, CEP 05503-900 São Paulo, SP, Brazil.
Vet Res Commun. 2008 Apr;32(4):281-90. doi: 10.1007/s11259-007-9029-3. Epub 2007 Dec 11.
IgY is a chicken egg yolk antibody which has been used for treatment and prophylaxis of gastrointestinal infections. Our aim was to verify if IgY obtained from chickens immunized with EPEC O111, STEC O111 and STEC O157 is able to show in vitro reactivity and biological activity towards the three bacteria. IgY was obtained from eggs laid before and after immunization with each bacterium. The preparations of IgY anti-EPEC O111 and anti-STEC O111 shared high reactivity detected by ELISA and growth inhibition ability towards both bacteria EPEC O111 and STEC O111. Nevertheless, the preparation of IgY anti-STEC O157 showed high reactivity and growth inhibitory effect only towards the homologous strain. Our results showing in vitro biological activity of IgY reinforce its use as an alternative for the treatment or prophylaxis of E. coli infections and encourage the development of in vivo studies for a possible future human therapeutic use.
卵黄免疫球蛋白(IgY)是一种鸡蛋蛋黄抗体,已被用于治疗和预防胃肠道感染。我们的目的是验证用肠致病性大肠杆菌O111(EPEC O111)、产志贺毒素大肠杆菌O111(STEC O111)和产志贺毒素大肠杆菌O157(STEC O157)免疫的鸡所获得的IgY是否能够在体外对这三种细菌表现出反应性和生物活性。IgY是从用每种细菌免疫前后所产的鸡蛋中获得的。通过酶联免疫吸附测定(ELISA)检测发现,抗EPEC O111和抗STEC O111的IgY制剂对EPEC O111和STEC O111这两种细菌具有高反应性和生长抑制能力。然而,抗STEC O157的IgY制剂仅对同源菌株表现出高反应性和生长抑制作用。我们的结果表明IgY在体外具有生物活性,这进一步证明了其可作为治疗或预防大肠杆菌感染的替代方法,并鼓励开展体内研究,以便未来有可能用于人类治疗。